Cathie Wood is long BEAM, But I will be Strong Short #CathieWood
Baught this stock...I analyzed it....and …...well....I would do exact the opposite......
But why?
Technical Analysis
Let forget eveything you know about technical analysis, and let together tell this story....logically..
At
76-71 USD AGGRESSIVE SELLERS FORCED THE PICE DOWN
29,72 USD BUYERS DEFENDED THIS Area(ZONE) as well the sellers took partial profits, and accumulated their positions ,but this time more powerfully and aggressive at 64-61USD zone
THE PRICE MOVED DOWN, Institutional buyers took patial profits,(the best decision they could do OTHERWISE THEY WOULD LOSE ALL THIER PROFITS LOOK AT THE PICE OF TODAY
The retail traders who followed the news and the hype baught Beam hoping that the share prce will fly to the moon,but......
At 64-61 who is waiting there?
YES THE AGGRESSIVE SELLERS!!!!
NOW THEY FORCED MUCH MORE ORDERS TO SEND THE PRICE To the....where we are now....
Bad for the buyers...Some buyers took profits, some took losses, and to compensate thier losses, they started to sell short the market....
At 28,80(YELLOW LINE) we are now at the weak support(low volume) The market could make a retracement to 44,94USD
where the sellers and BEARS are waiting of them.....to do what? Well you know it.....
Otherwise...more selles (former retail trades bulls) could decide to sell the maket from here....
WE HAVE A LONG DISTANCE TO GO DEEPER....
Targets short
13,75
8,68
3,82
1,25
.
.
Wood's flagship ARK Innovation ETF has loaded up in recent weeks on Beam Therapeutics (BEAM 1.11%). The gene-editing stock currently ranks as the ETF's 18th-largest holding. It's also the ninth-largest position in Wood's ARK Genomic Revolution ETF.
Beam Therapeutics is a pioneer in base editing. Most types of gene editing involve double-strand breaks in DNA that can cause random unwanted insertions and deletions. Base editing is highly precise, with no double-strand breaks and no off-target genetic changes. Because of these characteristics, base editing holds tremendous promise as a method for developing therapies targeting genetic diseases and "off the shelf" cell therapies for treating cancer.
So far, Beam has advanced two base-editing candidates into clinical testing. It's evaluating BEAM-101 as a treatment for two rare blood disorders: sickle cell disease and beta-thalassemia. And the company expects to begin dosing patients in a phase 1 study of experimental cancer cell therapy BEAM-201 by mid-2023.
Those two programs could be joined by two others soon. Beam hopes to submit for regulatory approvals to start clinical studies of BEAM-301 as a treatment for glycogen storage disease type 1a and BEAM-302 as a treatment for severe alpha-1 antitrypsin deficiency by early 2024.
The company has a long way to go. But if its base-editing programs prove to be safe and effective, Beam could be a massive winner.
Cathiewood
Cathie's woodShort term we saw a rough shaft descent as the Fed's interest rates caused high PE innovative companies to plummet. However we are now in a consolidating phase (right testicle consolidation) and companies such as Tesla doubled in value YTD.
In other words, Cathie's Wood will be trending up long term due to high interest in tech innovation. We expect investors to realize that innovation will outperform traditional industries (ex: AAPL, TSLA, MSFT, GOOG, etc). The ARKK fund is composed mostly of mid-cap stocks so there is a lot of upside potential before they become large caps.
ARKK - Still looks concerningHello friends, today you can review the technical analysis idea on a 1D linear scale chart for ARK Innovation ETF (ARKK).
The chart is self-explanatory. I have been providing warnings since December 2021 so I hope you followed along.
If you enjoy my ideas, feel free to like it and drop in a comment. I love reading your comments below.
Disclosure: This is just my opinion and not any type of financial advice. I enjoy charting and discussing technical analysis . Don't trade based on my advice. Do your own research! #millionaireeconomics
-3x Short ARKK ETP -> Santa Claus RallyGet on the sled of Santa Claus for your end of year rally. Take a look at Cathie Wood her picks in the ARKK ETF one more time and decide for yourself.
SARK has made some gains the past weeks, but now it's time to leverage this baby.
Buy in: 6.4 - 6.7
Target: 10.00
Stop-loss: 5.5
Not financial advice. Just sharing my ideas.
ARKK : The Innovation Fund. SELLCathie just published her Open letter for Fed. If a bottom stock picker tracks macro and starts advising the Central Bank about what to do, you know something is wrong in Paradise.
Technically speaking, the price chart has forming a H&S. Ten out of last 11 months have beeen negative months.It has grossly underperformed all the possible indices .
Fundamentally speaking the FAANGs & MAMAA's of the world are still grossly overvalued in the interest rate stabilising world, note it that I never said rising, because as one of the factors of production, the price of money should never have been negative.
Can you fathom a negative Salary for your monthly efforts ??
My Target for this overhyped overblown Fund is $29.30.
ARKK - My Third WarningHello friends, today you can review the technical analysis idea on a 1W linear scale chart for ARK Innovation ETF (ARKK).
The chart is self-explanatory. I have been providing warnings since December 2021 so I hope you followed along. Included in this chart is the Keltner Channel, recent Death Cross (50 SMA / 200 SMA), RSI, Volume. This is a weekly chart so have patience. There are two support and resistance areas noted with price ranges.
If you enjoy my ideas, feel free to like it and drop in a comment. I love reading your comments below.
Disclosure: This is just my opinion and not any type of financial advice. I enjoy charting and discussing technical analysis . Don't trade based on my advice. Do your own research! #millionaireeconomics
NVTA Invitae Corporation Options Ahead Of EarningsLooking at the NVTA Invitae Corporation options chain, i would buy the $2.5 strike price calls with
2023-1-20 expiration date for about
$0.60 premium.
Looking forward to read your opinion about it.
$ARKK Finally a buy ? ARKK - The bearish sentiment and hate against miss Cathie Wood is pretty strong as her flagship ARKK fund has gone from a high of $160 to low $35 this past week, nearly erasing ALL gains and now total 5 year return in line with the market at 13.8%. If you're a contrarian, you love the idea of going long here.
I prefer technical and price action which as of now I think ARKK has a good R/R and am looking for a trade to $55 price target in the near term.
- Huge volume last week as sellers appear to be exhausting and a bullish hammer candle
- Currently at FOUR year support line
- RSI in over sold zone
- PT 55 coincides nicely with 10weeklyMA at 56
- Even in bear markets we see upside rallies (another opportunity to short)
This is a trade idea, as a longer term investor I'd be waiting for a solid base and breakout above 30wkMA, and I still see any bull rally in this name as another opportunity to go short.
Further downside is limited and favor the risk return down here.
Let's see :)
ARKK fund price targetsWith investors moving from growth stocks to the safest dividend paying sector companies, the ARKK fund finds itself in a difficult position.
Once the interest rates go higher and money will be harder to borrow, my price targets from this ETF are $60, respectively $49 by the end of Q2.
Looking forward to read your opinion about it.
Peloton correction coming?Peloton
Short Term - We look to Buy at 11.87 (stop at 11.05)
Preferred trade is to buy on dips. Although the anticipated move higher is corrective, it does offer ample risk/reward today. Previous support located at 12.00. We look for a temporary move higher.
Our profit targets will be 14.31 and 15.49
Resistance: 14.50 / 15.80 / 24.50
Support: 12.00 / 10.00 / 5.00
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
ARKK ARK Innovation: 1D Chart ReviewHello friends, today you can review the technical analysis idea on a 1D linear scale chart for ARK Innovation ETF (ARKK).
The chart is self-explanatory. The price is currently in a Descending Parallel Channel with the RSI oversold so there may be a short term upward price movement, however the overall trend is still down. I put in multiple support lines to keep an eye on. If price moves back up, expect the areas I noted as major resistance areas.
Included in the chart: Trend line, Support and Resistance Lines, Volume, RSI, MFI ( Money Flow Index), Descending Parallel Channel.
If you enjoy my ideas, feel free to like it and drop in a comment. I love reading your comments below.
Disclosure: This is just my opinion and not any type of financial advice. I enjoy charting and discussing technical analysis . Don't trade based on my advice. Do your own research! #cryptopickk
BITCOIN: CATHIE WOOD WAS RIGHTHi guys, i think that after all Cathie Wood could have right on Bitcoin projection.
However she manage billions of dollars, so why don't follow in her analyses?
500k is not a small target, by 2030 means that Bitcoin will have reach 10 trillion market cap, not a small deal for sure.
Your thoughts?
BITCOIN is setting for a big resetI expect Bitcoin to be in a bear market for the next 2-3 years. Big reset is coming in Bitcoin and no one expects it. Take your profit off the market and wait the right moment to get in. People like Michael Saylor and Cathie Wood will loose hell a lot of a money and once Bitcoin reach a $21000 a margin call will start to hit this guys. Be prepared!
ARKK and Cathie Wood = trouble
AMEX:ARKK
Like many people, I've lost $$$ falling in love with Cathie
Cathie has literally destroyed my portfolio.
Does shares bought at $150-$130 are now worth a quarter of that.
What is going on with ARKK and are we going to see more lows?
News:
All ARKK ETF’s continue to underperform relative to the S&P 500 is growing and Teladoc Health, one of ARK Innovation ETF’s most overweight positions, just collapsed in value last week.
Unlike Bill Ackman who dumped his funds $1.1 billion investment in NFLX and taking a loss of around $400 million, Madam Cathie is adding more to her position.
Charts:
EMA ( Exponential Moving Average ): Price action is below the 200 EMA (discount buying opportunity) Price is also below 20/50/100/200 EMA and are all pointing downwards! Looks like we've been in a death cross since November 2021 and we're not coming out of it anytime soon.
TTM Squeeze: Squeezing to the bottom but it looks like it wants to change direction at the current support line (super trendline; at the bottom of the pattern).
Fib Levels: with the price below the 1 fib and headed towards the 1.618, if the current support support line doesn't hold, we could see $ARKK in the $30s...(bye bye to my $44K leap call option expiring in December).
Candle Stick: Summary of last 5 candles equate to a bearish movement; you might as well just call them a 3 black crow.
RSI: In a great position which also supports the TTM Squeeze movement... No matter what happens on May 3rd or 4th, I should just buy some more at this point.
Pattern: Falling Wedge and still falling; Need a savior.
History: ARKK seems to have lost it's hedge and it's now crashing and burning; a breakthrough will be nice.
Privacy vs. Transparency ARK CTRU vs Zcash“Surveillance capitalism unilaterally claims human experience as free raw material for translation into behavioral data.”
In an era where Cathie Wood launched a fund about business and financial surveillance
the counter narrative will be in support of freedom and privacy.
Zcash vs. ARK which will win?
WAS ROKU sell-off predictable??Of course it was! The Double Top is one of the most obvious chart patters you can find:
And i think it might go just where it all started: at the Covid lockdown level of $59.
I know that today ARK bought around 400K shares, but i think they are wrong, ROKU hasn`t bottomed yet!
Looking forward to read your opinion about it.
Is the bearish trend finished? ARKK.Today I will share my view on Cathie Wood's ETF and the pending setup I have.
* The main structure of the current situation is the yellow descending channel , where we have been observing several contacts there.
* The confirmation for me to start thinking about bullish opportunities happened when the inner descending channel was broken.
* After that, I decided to wait for 4 days of corrective movement (which had already happened) and define activation levels on a new high. (green horizontal line)
* The invalidation level or stop loss for this situation, if the price reaches my activation level, is 62.00. I will consider that my view was wrong; therefore, I close my position on a 1% loss.
*If the previous scenario is true, I will make a re-entry on a new local high, following the same concept as before.
*I'm doing this because I think the upside potential is really good ( target on the end of the green arrow ), which provides a risk to reward ratio of around 4.5. That's why I have a re-entry plan; even if I'm stopped out 3 times until I can catch the real movement, the setup would still be profitable.
Thanks for reading; feel free to share your view and comments on the chart.
ARKK possibly worth a swing for relief rallyJust tossing this one out there:
Cathie Wood's ARKK Innovation ETF is within 1% of completing a round-trip to its pre-pandemic highs. It's also at the bottom of a fairly major parallel channel that it's been forming since February last year. In purely technical terms, it looks poised for a bounce.
This is not a long-term hold, especially with Tesla as the top holding. Valuations remain high, and Tesla is being investigated by the SEC. I also wouldn't use call options to play this. The options premiums are super expensive. I'm just thinking buy a few shares for a technical bounce, and maybe sell at the 20-day EMA.
Counterintuitively, the Russia-Ukraine crisis is a possible catalyst for a bounce. Forecasters seem to think that conflict in Ukraine will make the Fed more dovish this year, with fewer rate hikes than previously expected. $ARKK has been super sensitive to interest rate expectations, so it might be bullish for the ETF if rate expectations ease a bit.
One nice thing about this trade: since we're so close to channel bottom, you can put a stop loss right beneath the channel.
2 Years later, ARKK is in the same place. Today I will update my view on ARKK from the previous post I made.
I found it super interesting to see how one of the most renowned assets in the post-pandemic era has erased ALL its gains from the beginning of the bear market back in February 2020 until now.
From a logarithmic perspective, we can see that the current decline is the deepest one and almost doubled previous declines.
Now I would like to go into technical elements and the situation where we may have interesting trading opportunities.
I am still paying attention to the internal descending trendline. Trendlines are incredible tools to help you avoid getting into the market at the wrong moment. For example, here, the descending trendline can be interpreted as "Below the trendline, avoid bullish setups. Above the trendline, start thinking in bullish setups."
But that's not all; I don't want to see a breakout of the descending trendline only. I want to observe a clear correction with the proportions you can see on the circle. IF that happens, I will trade on a new local high towards the higher zone of the descending channel. If nothing of that happens, because the price keeps falling into the ugliest correction of all, I would stay on the sidelines until the technical elements confirm that we are in a good situation to develop setups.
Thanks for reading; feel free to share your view and charts in the comments.